We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current AXRX market cap is 338.21k. The company's latest EPS is USD 0.0002 and P/E is 0.00.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 7.72M | 6.37M | 4.82M | 4.43M | 3.92M |
| Operating Income | 495k | 502k | 356k | 113k | 209k |
| Net Income | 217k | 196k | 74k | 69k | 36k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 2.47M | 3.7M | 2.88M | 2.57M | 2.46M |
| Total Liabilities | 1.21M | 2.18M | 1.23M | 849k | 707k |
| Total Equity | 1.27M | 1.52M | 1.65M | 1.72M | 1.75M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | N/A | N/A | N/A | N/A | N/A |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | N/A | N/A | N/A | N/A | N/A |
| Market Cap | 338.21k |
| Price to Earnings Ratio | 0.00 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 169.11M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | 0.00% |
| 52 Week High | 0.0021 |
| 52 Week Low | 0.002 |
| Spread (Intraday) | 0 (0%) |
| Company Name | AmexDrug Corporation (CE) |
| Address |
318 n carson carson city, nevada 89701 |
| Website | https://www.amexdrug.com |
| Industry | drugs and proprietary-whsl (5122) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
